August 30, 2011 — Dilon Diagnostics announced it has added several PenRad products to its portfolio of women’s imaging technology, including the PenRad Mammography Information System (MIS) and Volpara, a quantitative breast density assessment tool.
Dilon specializes in compact gamma cameras that support breast-specific gamma imaging/molecular breast imaging (BSGI/MBI) studies. BSGI/MBI is a procedure that sees lesions independent of tissue density and provides a functional imaging complement to the anatomical imaging of mammography. It is particularly useful for patients with equivocal mammograms, dense breast tissue and for help with determining the extent of disease.
Volpara converts the qualitative breast X-ray image into quantitative data. Breast tissue density has not only been linked to an increased risk of breast cancer, it also decreases the sensitivity of the mammogram and thereby may impact early detection.
The software is designed to assist radiologists by objectively and automatically assessing a woman's breast density, and facilitates breast centers' compliance with new legislation and notification guidelines. PenRad automatically integrates the information from Volpara and BSGI/MBI into the routine MIS workflow.
For more information: www.dilon.com
April 20, 2026 
